Immuno-oncology, particularly immune checkpoint inhibitors (ICIs), is rapidly evolving in the treatment of several human cancers by enhancing and increasing the ability of the immune system to generate an antitumor response against cancer cells through natural mechanisms that are evaded or damaged during disease progression. The introduction of ICIs has become a promising frontier for the treatment of several solid tumors, such as the non-small-cell lung cancer, melanoma, renal cell carcinoma, but also small-cell lung cancer, and breast, cervical, bladder, colorectal, gastric and liver tumors. In this chapter, we aimed to summarize all novel implementations of liquid biopsy in the evolving landscape of immunotherapy agents.

Incorvaia L., Perez A., Brando C., Gristina V., La Mantia M., Castiglia M., et al. (2022). Liquid biopsy and immunotherapy: is all that glitter gold?. In Liquid Biopsy: New Challenges in the era of Immunotherapy and Precision Oncology (pp. 83-117). Elsevier [10.1016/B978-0-12-822703-9.00005-3].

Liquid biopsy and immunotherapy: is all that glitter gold?

Incorvaia L.;Brando C.;Gristina V.;Fanale D.;Galvano A.;Badalamenti G.;Russo A.;Bazan V.
2022-01-01

Abstract

Immuno-oncology, particularly immune checkpoint inhibitors (ICIs), is rapidly evolving in the treatment of several human cancers by enhancing and increasing the ability of the immune system to generate an antitumor response against cancer cells through natural mechanisms that are evaded or damaged during disease progression. The introduction of ICIs has become a promising frontier for the treatment of several solid tumors, such as the non-small-cell lung cancer, melanoma, renal cell carcinoma, but also small-cell lung cancer, and breast, cervical, bladder, colorectal, gastric and liver tumors. In this chapter, we aimed to summarize all novel implementations of liquid biopsy in the evolving landscape of immunotherapy agents.
2022
Incorvaia L., Perez A., Brando C., Gristina V., La Mantia M., Castiglia M., et al. (2022). Liquid biopsy and immunotherapy: is all that glitter gold?. In Liquid Biopsy: New Challenges in the era of Immunotherapy and Precision Oncology (pp. 83-117). Elsevier [10.1016/B978-0-12-822703-9.00005-3].
File in questo prodotto:
File Dimensione Formato  
LB and immunotherapy.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 624.05 kB
Formato Adobe PDF
624.05 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/625461
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact